135 related articles for article (PubMed ID: 19378204)
41. An experimental model of focal ischemia using an internal carotid artery approach.
Boyko M; Zlotnik A; Gruenbaum BF; Gruenbaum SE; Ohayon S; Goldsmith T; Kotz R; Leibowitz A; Sheiner E; Shapira Y; Teichberg VI
J Neurosci Methods; 2010 Nov; 193(2):246-53. PubMed ID: 20817031
[TBL] [Abstract][Full Text] [Related]
42. Mesenchymal stem cells derived from peripheral blood protects against ischemia.
Ukai R; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
J Neurotrauma; 2007 Mar; 24(3):508-20. PubMed ID: 17402856
[TBL] [Abstract][Full Text] [Related]
43. Comparison of silicon-coated nylon suture to plain nylon suture in the rat middle cerebral artery occlusion model.
Shimamura N; Matchett G; Tsubokawa T; Ohkuma H; Zhang J
J Neurosci Methods; 2006 Sep; 156(1-2):161-5. PubMed ID: 16569436
[TBL] [Abstract][Full Text] [Related]
44. Middle Cerebral Artery Occlusion by an Intraluminal Suture Method.
Crupi R; Di Paola R; Esposito E; Cuzzocrea S
Methods Mol Biol; 2018; 1727():393-401. PubMed ID: 29222799
[TBL] [Abstract][Full Text] [Related]
45. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats.
Gerriets T; Li F; Silva MD; Meng X; Brevard M; Sotak CH; Fisher M
J Neurosci Methods; 2003 Jan; 122(2):201-11. PubMed ID: 12573479
[TBL] [Abstract][Full Text] [Related]
46. Complications and pitfalls in rat stroke models for middle cerebral artery occlusion: a comparison between the suture and the macrosphere model using magnetic resonance angiography.
Gerriets T; Stolz E; Walberer M; Müller C; Rottger C; Kluge A; Kaps M; Fisher M; Bachmann G
Stroke; 2004 Oct; 35(10):2372-7. PubMed ID: 15345802
[TBL] [Abstract][Full Text] [Related]
47. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats.
Mitkari B; Kerkelä E; Nystedt J; Korhonen M; Mikkonen V; Huhtala T; Jolkkonen J
Exp Neurol; 2013 Jan; 239():158-62. PubMed ID: 23059455
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
[TBL] [Abstract][Full Text] [Related]
49. [Adipose-derived stem cell transplantation inhibits the expression of Nogo-A in the perilesional cortex of rats with focal cerebral ischemia].
Wang J; Li G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):39-43. PubMed ID: 26728376
[TBL] [Abstract][Full Text] [Related]
50. Modeling stroke in mice - middle cerebral artery occlusion with the filament model.
Engel O; Kolodziej S; Dirnagl U; Prinz V
J Vis Exp; 2011 Jan; (47):. PubMed ID: 21248698
[TBL] [Abstract][Full Text] [Related]
51. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
Honma T; Honmou O; Iihoshi S; Harada K; Houkin K; Hamada H; Kocsis JD
Exp Neurol; 2006 May; 199(1):56-66. PubMed ID: 15967439
[TBL] [Abstract][Full Text] [Related]
52. Intraluminal middle cerebral artery occlusion (MCAO) model for ischemic stroke with laser doppler flowmetry guidance in mice.
Ansari S; Azari H; McConnell DJ; Afzal A; Mocco J
J Vis Exp; 2011 May; (51):. PubMed ID: 21587164
[TBL] [Abstract][Full Text] [Related]
53. Effect of suture properties on stability of middle cerebral artery occlusion evaluated by synchrotron radiation angiography.
Guan Y; Wang Y; Yuan F; Lu H; Ren Y; Xiao T; Chen K; Greenberg DA; Jin K; Yang GY
Stroke; 2012 Mar; 43(3):888-91. PubMed ID: 22180249
[TBL] [Abstract][Full Text] [Related]
54. The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rate.
Grudzenski S; Baier S; Ebert A; Pullens P; Lemke A; Bieback K; Dijkhuizen RM; Schad LR; Alonso A; Hennerici MG; Fatar M
Stem Cell Res Ther; 2017 Apr; 8(1):96. PubMed ID: 28446216
[TBL] [Abstract][Full Text] [Related]
55. Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats.
Yamashita T; Sasaki M; Sasaki Y; Nagahama H; Oka S; Kataoka-Sasaki Y; Ukai R; Yokoyama T; Kobayashi M; Kakizawa M; Kocsis JD; Honmou O
Brain Res; 2024 Feb; 1825():148709. PubMed ID: 38072373
[TBL] [Abstract][Full Text] [Related]
56. Optimizing suture middle cerebral artery occlusion model in C57BL/6 mice circumvents posterior communicating artery dysplasia.
Yuan F; Tang Y; Lin X; Xi Y; Guan Y; Xiao T; Chen J; Zhang Z; Yang GY; Wang Y
J Neurotrauma; 2012 May; 29(7):1499-505. PubMed ID: 22054164
[TBL] [Abstract][Full Text] [Related]
57. Using a neodymium magnet to target delivery of ferumoxide-labeled human neural stem cells in a rat model of focal cerebral ischemia.
Song M; Kim YJ; Kim YH; Roh J; Kim SU; Yoon BW
Hum Gene Ther; 2010 May; 21(5):603-10. PubMed ID: 20059319
[TBL] [Abstract][Full Text] [Related]
58. Long-term survival in permanent middle cerebral artery occlusion: a model of malignant stroke in rats.
Shanbhag NC; Henning RH; Schilling L
Sci Rep; 2016 Jun; 6():28401. PubMed ID: 27329690
[TBL] [Abstract][Full Text] [Related]
59. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
Omori Y; Honmou O; Harada K; Suzuki J; Houkin K; Kocsis JD
Brain Res; 2008 Oct; 1236():30-8. PubMed ID: 18722359
[TBL] [Abstract][Full Text] [Related]
60. Adverse effects of the intraluminal filament model of middle cerebral artery occlusion.
Dittmar MS; Fehm NP; Vatankhah B; Bogdahn U; Schlachetzki F
Stroke; 2005 Mar; 36(3):530-2; author reply 530-2. PubMed ID: 15738577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
